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Respiratory syncytial virus (RSV) infection is the major cause of bronchiolitis in young
children. The factors that contribute to the increased propensity of RSV-induced distal
airway disease compared with other commonly encountered respiratory viruses remain
unclear. Here, we identified the RSV-encoded nonstructural 2 (NS2) protein as a viral
genetic determinant for initiating RSV-induced distal airway obstruction. Infection of human
cartilaginous airway epithelium (HAE) and a hamster model of disease with recombinant
respiratory viruses revealed that NS2 promotes shedding of infected epithelial cells,
resulting in two consequences of virus infection. First, epithelial cell shedding accelerated
the reduction of virus titers, presumably by clearing virus-infected cells from airway mucosa.
Second, epithelial cells shedding into the narrow-diameter bronchiolar airway lumens
resulted in rapid accumulation of detached, pleomorphic epithelial cells, leading to acute
distal airway obstruction. Together, these data indicate that RSV infection of the airway
epithelium, via the action of NS2, promotes epithelial cell shedding, which not only
accelerates viral clearance but also contributes to acute obstruction of the distal airways.
Our results identify RSV NS2 as a contributing factor for the enhanced propensity of RSV to
cause severe airway disease in young children and suggest NS2 as a potential therapeutic
target for reducing the severity of distal airway disease.
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Respiratory syncytial virus (RSV) infection is the major cause of bronchiolitis in young children. The factors 
that contribute to the increased propensity of RSV-induced distal airway disease compared with other com-
monly encountered respiratory viruses remain unclear. Here, we identified the RSV-encoded nonstructural 2 
(NS2) protein as a viral genetic determinant for initiating RSV-induced distal airway obstruction. Infection of 
human cartilaginous airway epithelium (HAE) and a hamster model of disease with recombinant respiratory 
viruses revealed that NS2 promotes shedding of infected epithelial cells, resulting in two consequences of 
virus infection. First, epithelial cell shedding accelerated the reduction of virus titers, presumably by clearing 
virus-infected cells from airway mucosa. Second, epithelial cells shedding into the narrow-diameter bronchi-
olar airway lumens resulted in rapid accumulation of detached, pleomorphic epithelial cells, leading to acute 
distal airway obstruction. Together, these data indicate that RSV infection of the airway epithelium, via the 
action of NS2, promotes epithelial cell shedding, which not only accelerates viral clearance but also contrib-
utes to acute obstruction of the distal airways. Our results identify RSV NS2 as a contributing factor for the 
enhanced propensity of RSV to cause severe airway disease in young children and suggest NS2 as a potential 
therapeutic target for reducing the severity of distal airway disease.
Introduction
Human respiratory syncytial virus (RSV) is a nonsegmented, neg-
ative-sense, single-stranded RNA virus belonging to the family 
Paramyxoviridae, subfamily Pneumovirinae. RSV is the most com-
mon virus responsible for acute and severe lower airway disease in 
infants and young children, with nearly all children experiencing 
at least one RSV infection by the age of 2 years (1). While most RSV 
infections present with mild to moderate self-limiting pulmonary 
symptoms, in approximately 2% of cases, especially in infants who 
are very young (<3 months), premature, or who have underlying 
immunodeficiency or cardiopulmonary disease, lower airway dis-
ease is severe enough to require hospitalization (2). Worldwide, an 
estimated 34 million new pediatric cases of RSV-associated lower 
airway disease occur annually, accounting for approximately 
200,000 deaths, almost all of which occur in developing countries 
with reduced access to standardized care (3).
Despite significant impact of RSV infection on infant mor-
bidity and mortality, treatment options remain limited largely 
to supportive care. Ribavirin is the only antiviral drug currently 
approved for treating RSV infections, but issues of efficacy, 
delivery, and toxicity restrict its use to immunocompromised 
patients (4). Bronchodilators and anti-inflammatory steroids 
are widely prescribed to dampen the inflammatory conse-
quences of RSV infection, despite evidence that these treatments 
provide little to no clinical benefit (5–7). Prophylactic use of pas-
sively administered neutralizing antibodies is effective in reduc-
ing RSV-associated hospitalization in susceptible populations, 
but these antibody treatments are expensive and inconvenient, 
and are limited to at-risk infants (8, 9). Licensed RSV vaccines 
are currently unavailable but are under active development. The 
high incidence of RSV infection and the potential for severe dis-
tal airway disease in vulnerable young children, combined with 
limited availability of therapeutic options, identifies a signifi-
cant global human health need.
RSV infects the mucosal epithelium lining the human respi-
ratory tract, predominantly targeting the columnar epithelial 
cells of the conducting airways. The columnar airway epithelium 
provides critical innate defense functions important for main-
taining lung sterility. Airway epithelial cells respond to inhaled 
pathogens by secreting antimicrobials and recruiting inflamma-
tory cell infiltrates important for clearing infection and subse-
quent tissue repair. The airway epithelium also uniquely provides 
mechanical clearance of inhaled pathogens by facilitating unidi-
rectional mucus transport, largely due to synchronous beating of 
cilia and regulated mucin secretion. Precisely how RSV infection 
affects innate functions of the columnar airway epithelium and 
how this relates to subsequent RSV-associated disease is poorly 
defined, largely due to the limited availability of human airway 
pathology specimens obtained during early RSV infection. In 
the limited postmortem studies available from RSV-infected 
infants, it was noted that epithelial cells positive for RSV anti-
gen were sloughed into the lumens of infected airways, leading 
to speculation that intralumenal accumulations of infected and 
necrotic epithelial cells could contribute to airway obstruction 
and inflammation, exacerbating airway disease (10–12). Whether 
sloughing of airway epithelial cells was a direct consequence of 
RSV-induced epithelial cell cytopathology or a bystander effect 
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of the robust infiltration of inflammatory cells into the infected 
airways has been difficult to decipher in the complex in vivo envi-
ronment of the lung.
We previously described an in vitro model of RSV infection of 
human cartilaginous airway epithelium (HAE) that recapitulates 
the cellular distribution and physiology of the human differen-
tiated airway epithelium. Using this model, we and others have 
shown that RSV infects and spreads in HAE by preferentially 
infecting ciliated epithelial cells while sparing mucin-contain-
ing Goblet cells and the underlying basal epithelial cells (13, 14). 
These in vitro findings are supported by histologic studies of car-
tilaginous airways from RSV-infected patients that also demon-
strate the preferential tropism of RSV for ciliated cells (10). Tro-
pism for ciliated cells is not unique to RSV, as other RNA viruses, 
including paramyxoviruses, coronaviruses, and avian influenza 
viruses, have been shown to preferentially infect ciliated cells in 
the HAE model (15–17).
Our previous studies demonstrated that RSV infection of 
human ciliated cells in HAE was minimally cytopathic, at least 
within the first 48 hours of infection (14). The lack of direct 
RSV-induced cytopathology was in contrast to the rapid and 
robust cytopathology documented in HAE infected by influenza 
viruses (18). In the present study, we have expanded our earlier 
studies with RSV to track the fate of RSV-infected ciliated cells 
over time and to determine consequences of infection potentially 
important for pathogenesis. By tracking the fate of ciliated cells 
infected by RSV in vitro, we identified a unique consequence of 
RSV infection whereby infected ciliated cells rapidly transitioned 
from a columnar to a rounded cell morphology and were then 
extruded from the otherwise intact epithelium. Once shed, the 
detached RSV-infected cells were incorporated into lumenal 
mucus secretions of HAE and were transported by the directional 
flow of mucus secretions. Using RSV gene deletion mutants, cili-
ated cell rounding after RSV infection was attributed to the RSV 
non-structural 2 (NS2) protein. Gain-of-function experiments 
using recombinant, GFP-expressing parainfluenza virus 3 (PIV3- 
GFP) engineered to express RSV NS2 (PIV3-NS2) demonstrated 
that ciliated cells infected with PIV3-NS2, but not with PIV3, 
became rounded and morphologically indistinguishable from 
ciliated cells infected with RSV. To explore potential in vivo func-
tions of RSV NS2 expression, we infected the airways of Golden 
Syrian hamsters with PIV3-NS2 or PIV3 and show that PIV3-NS2 
caused rapid shedding of infected epithelial cells from the air-
way epithelium, which coincided with accelerated clearance of 
virus infection from hamster lungs. These studies also revealed 
an unexpected consequence of PIV3-NS2 infection of the narrow-
er-diameter bronchiolar airways, in which PIV3-NS2 but not PIV3 
caused sufficient intralumenal accumulations of shed epithelial 
cells to partially or fully occlude the bronchiolar airway lumens. 
These findings suggest that acute, distal airway obstruction, a 
common feature of RSV infection in infants, may be due to the 
rapid shedding of RSV-infected bronchiolar epithelial cells into 
the airway lumen and that this event is a direct consequence of 
RSV NS2 expression. To our knowledge, these studies provide the 
first description of the unique fate of RSV-infected columnar air-
way epithelial cells and identify a novel property of the RSV NS2 
protein as promoting this event.
Results
Kinetics of RSV replication in HAE. The kinetics of RSV infection in 
HAE was measured by inoculating the apical surface of cultures 
with a recombinant RSV expressing GFP inserted between the 
phosphoprotein (P) and matrix (M) genes (3 × 105 PFU; MOI ~1), 
and the numbers of GFP-positive cells and titers of released virus 
were determined every 24 hours for 8 days. Representative en face 
images of GFP-positive cells and quantification of the percentage 
of epithelium surface area positive for GFP across HAE obtained 
from multiple tissue donors are shown in Figure 1, A and B, 
respectively. At day 1 post-inoculation (pi), RSV infection resulted 
in 5% of the epithelium surface area positive for GFP, and over 
time the extent of infection steadily increased as virus infection 
spread, with 53% of the epithelium surface area being GFP-positive 
Figure 1
RSV-GFP infection, replication, 
and clearance in HAE cultures. 
(A) Representative en face fluo-
rescent images of GFP-positive 
cells in HAE infected with RSV 
expressing GFP at days 1, 3, 5, 
and 7 pi. Scale bar: 200 μm. (B) 
The number of RSV-infected cells 
in HAE over time, quantified as 
the percentage of the epithelium 
surface area positive for GFP 
fluorescence. (C) Virus titers 
present in the airway surface fluid 
over time. Data (mean ± SEM) 
are representative of independent 
experiments utilizing at least 4 
cultures per donor obtained from 
3 different donors.
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by day 4 pi. Beyond day 4 pi, the numbers of GFP-positive cells 
declined rapidly, and by day 8 pi, infected cell numbers approxi-
mated those at day 1 pi In agreement with previous studies (14), 
only ciliated cells expressed GFP, which confirmed RSV tropism 
for ciliated cells in this model. On average, ciliated cells repre-
sented approximately 90% of the surface columnar epithelial cells 
in HAE, indicating that approximately 60% of available ciliated 
cells were infected by RSV at the time of maximal infection (day 4). 
Throughout infection, HAE cultures remained intact based on 
gross visual inspection, as previously described (14, 17).
RSV titers in washes harvested from the apical surfaces of 
HAE paralleled the numbers of GFP-positive cells (Figure 1C). 
RSV titers steadily increased proportionate to the numbers of 
GFP-positive cells during the first 3 days of infection, reaching 
maximal titers by day 4 pi (2.6 × 106 PFU/ml). Once maximal, 
virus titers declined proportionate to the loss of GFP-positive 
cells, and by day 8 pi, virus titers had fallen by 2 logs 
compared to those at day 4 pi (Figure 1C). The rapid net 
loss of RSV infection from HAE between days 4 and 8 pi 
suggests that most of the RSV-infected ciliated cells were 
cleared from the epithelium during this period and, as 
HAE are pure populations of epithelial cells, that clear-
ance of infected ciliated cells occurred in the absence of 
immune cell–mediated clearance mechanisms.
A distinctive morphologic change in RSV-infected colum-
nar airway cells. To investigate how RSV-infected (GFP- 
positive) ciliated cells were cleared from HAE, we used his-
tologic analysis to track the fate of infected ciliated cells 
over time. These studies revealed that RSV-infected cili-
ated cells underwent a distinctive morphologic transition 
from the native columnar cell morphology to a rounded 
cell morphology while remaining embedded in the epithe-
lium (Figure 2A). Ciliated epithelial cells of both human 
cartilaginous airway epithelium in vivo and HAE cultures 
in vitro are characteristically columnar, with individual 
ciliated cells spanning the depth of the epithelium and 
the ciliated cell tail intercalating into the underlying basal 
epithelial cell layers. Histologic assessment of ciliated cell 
rounding in vitro revealed that RSV infection caused a 
rapid retraction of the ciliated cell tails, which resulted 
in the infected cell assuming a rounded shape. Only 
GFP-positive ciliated cells (i.e., infected with RSV) exhib-
ited rounded cell morphology, and no GFP-positive cells 
were observed that retained the native columnar shape of 
ciliated cells, suggesting that ciliated cell rounding was a 
direct consequence of RSV infection.
Ciliated cells infected by RSV also began to bulge from 
the epithelial layer into the lumenal compartment and 
were eventually extruded from the epithelium (Figure 2A). 
During the extrusion process, the bulging apical mem-
branes of RSV-infected cells progressively lost apical 
structural components of ciliated cells, including cilia, as 
demonstrated by loss of β-tubulin IV immunoreactivity 
(Figure 2A) and a marked thinning of the cytoskeletal ter-
minal web (see arrows in Figure 2A). Despite significant 
disruption of apical structures in these bulging ciliated 
cells, the cells retained GFP fluorescence, suggesting that 
plasma membrane permeability was not overtly compro-
mised (Figure 2A). High-power transmission electron 
microscopy (TEM) studies of noninfected and RSV-in-
fected HAE, fixed to preserve the hydrated external environ-
ment of the HAE lumenal surface, confirmed that RSV infection 
resulted in the disintegration of apical structures, most notably 
cilia shafts and microvilli (Figure 2B). Basal bodies, usually orga-
nized directly below emerging cilia shafts, were often disorga-
nized in the cytoplasm of RSV-infected ciliated cells (asterisk in 
Figure 2B). Clouds of particulate matter in the external lumenal 
environment were composed of fragmented cilia and microvilli 
directly above bulging RSV-infected ciliated cells. It is reasonable 
to presume that these particulate clouds also contain progeny 
RSV virions and, on occasion, structures resembling RSV virions 
were detected (arrow in Figure 2B). More conclusive identifica-
tion of RSV virions in these clouds was technically challenging, 
as immunogold labeling of virus proteins would not discriminate 
between infectious progeny virions and virus proteins associated 
with fragmented cellular debris.
Figure 2
Morphologic and structural changes in RSV-infected ciliated columnar cells.  
(A) Representative histologic sections of HAE inoculated with RSV express-
ing GFP and counterstained with H&E or immunoprobed for GFP (green) and 
β-tubulin IV (red) at days 1, 3, and 5 pi. Yellow outlines at top left depict the differ-
ent ciliated cell morphologies seen in RSV-infected HAE, where noninfected cili-
ated cells are columnar and RSV-infected ciliated cells exhibit rounded morphol-
ogy. Arrowheads indicate robust apical terminal web in noninfected ciliated cells 
(top left), which thins in RSV-infected ciliated cells with rounded morphology (top 
right). Images are representative of independent experiments with 4 different 
donor cultures. Scale bar: 10 μm. (B) Representative TEM of cross-sections of 
the apical surfaces of noninfected (left) and RSV-GFP–infected (center, right) 
HAE. Arrowhead indicates particulates showing virus-like morphology. Asterisk 
indicates disorganized basal bodies. Scale bars: 1 μm.
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Shedding of epithelial cells from RSV-infected HAE. To further assess 
the cytopathology of RSV-infected cells, we examined histologic 
sections of noninfected and RSV-infected HAE fixed to preserve 
airway surface secretions accumulated over a 5-day period. In 
noninfected HAE, only occasional detached epithelial cells were 
present in accumulated mucus secretions (Figure 3A, top). In con-
trast, RSV-infected cultures contained large numbers of detached 
epithelial cells embedded in an increased mucus layer (Figure 3A, 
bottom). In addition to the increased number of detached cells 
in mucus secretions, the underlying intact epithelium of RSV- 
infected cultures was irregular in appearance, largely due to the 
rounded morphology of infected ciliated cells remaining in the 
epithelium. An overall decrease in cilia abundance also was noted 
in the RSV-infected epithelium.
We quantified the extent and kinetics of epithelial cell shedding 
from RSV-infected HAE cultures by determining the amount of 
dsDNA present in daily washes of the lumenal surfaces of noninfected 
and RSV-infected HAE (Figure 3B). Apical washes consistently con-
tained increased amounts of dsDNA at day 1 pi for both noninfected 
(mock-inoculated) and RSV-infected HAE, which we attribute to 
consequences of the inoculation procedure. However, by day 3 pi, 
there was a clear difference between RSV-infected and noninfected 
HAE in the amount of dsDNA present in apical washes, as dsDNA 
consistently increased in RSV-infected 
HAE cultures, reaching maximal levels 
at days 5 to 7 pi Amounts of dsDNA in 
apical washes from noninfected HAE 
remained low and constant over the 
same time period. The increased dsDNA 
in apical washes closely correlated with 
the loss of GFP-positive epithelial cells 
from HAE (Figure 1B), indicating the 
usefulness of dsDNA as a marker for 
the numbers of shed epithelial cells in 
airway secretions in vitro.
Overall, these observations suggest 
that the loss of GFP-positive cells from 
RSV-infected HAE is predominately 
due to shedding of the infected ciliated 
cells from the airway mucosa. RSV- 
infected epithelial cells, while rounded 
and extruding from the epithelium, 
exhibited no obvious nuclear abnor-
malities (Figure 3A) and were negative 
for TUNEL staining (data not shown), 
indicating that infected cells during 
the shedding process remained viable. 
Infected cells also retained GFP fluores-
cence, suggesting that the plasma mem-
brane of infected cells remained intact. 
In contrast, shed and detached epithe-
lial cells in mucus secretions on the api-
cal surface of HAE displayed well-char-
acterized nuclear structural changes 
indicative of cell death, and pykno-
sis (nuclear shrinkage), karyorrhexis 
(nuclear fragmentation), and karyoly-
sis (nuclear dissolution) were noted in 
shed epithelial cells (Figure 3A). These 
findings demonstrate that RSV-infected 
ciliated cells do not undergo overt cell death while embedded in the 
epithelium and that cell death in situ does not play a significant role 
in the clearance of RSV-infected cells from HAE. Rather, infected 
cells undergo cell death after becoming completely detached from 
the epithelium, although we have not been able to determine the 
precise kinetics of when shed cells die. We have also been unable to 
identify cellular mechanisms leading to death of shed cells. Never-
theless, since the reduction of RSV titers in HAE paralleled the loss 
of GFP-positive cells, we propose that shedding of RSV-infected cili-
ated cells, and not death while cells are embedded in the epithelium, 
represents the primary mechanism for clearing RSV infection from 
a differentiated airway epithelium, at least in vitro.
Effects of RSV infection on mucociliary transport. Extensive shedding 
of cells onto the lumenal surface of RSV-infected HAE suggests 
that, in vivo, this cellular material may be cleared from the airway 
lumen by mechanical clearance mechanisms, such as mucociliary 
transport (MCT). In vitro, we often observed shed and detached 
GFP-positive cells being transported within mucus secretions 
across the surface of cultures. Since directional transport of mucus 
secretions in HAE is dependent on coordinated cilia beat, the 
potential impact of RSV infection on the effectiveness of cilia func-
tion may adversely affect the ability of the airways to mechanically 
clear infection. We tested the consequence of RSV infection on 
Figure 3
Ciliated cell shedding and loss of cilia activity during RSV-GFP infection of HAE. (A) Representative 
images of histological cross-sections of noninfected HAE (top) or HAE infected with RSV expressing 
GFP (bottom) fixed at day 5 pi using a fixation protocol to preserve the content and depth of airway 
surface secretions. Scale bar: 20 μm. (B) Concentration of dsDNA as an index for numbers of shed 
cells present in apical washes harvested every 24 hours from noninfected (white circles) or RSV- 
infected (black squares) HAE. Data (mean ± SEM) were derived from 4 cultures per donor for 4 dif-
ferent donors. (C) Fluorescent bead velocity as an index of mucus transport rates on the apical sur-
faces of noninfected (white circles) or RSV-infected (black squares) HAE at indicated times pi. Data 
(mean ± SEM) represent 3–6 cultures per donor for 3 different donors. (D) Surface area of active 
cilia beat on noninfected (white circles) or RSV-infected (black squares) HAE. Data (mean ± SEM) 
represent 4 cultures. Data in B–D show significant differences at day 3 pi (P < 0.05) and at all time 
points thereafter (P < 0.001), as determined by unpaired t test.
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directional transport of particulates present in airway secretions 
by measuring MCT rates of 1-μm fluorescent beads transported 
across the lumenal surface of HAE (Figure 3C). For noninfected 
HAE, MCT rates of approximately 40 μm/s were maintained for 
6 consecutive days of experimental analysis. For RSV-infected 
HAE, MCT rates approximated those of noninfected HAE dur-
ing the first 2 days of RSV infection, despite infection of approxi-
mately 20% of the epithelium surface. However, by day 3 pi, RSV- 
infected HAE demonstrated a significant decline in MCT rate, and 
by day 4 pi, when approximately 60% of the epithelium surface 
was infected, MCT rates had fallen drastically to below 5 μm/s. 
By day 5 pi, bead transport in RSV-infected HAE had ceased.
To determine whether loss of MCT after RSV infection was 
directly associated with loss of cilia function, we also quantified 
the percentage of the epithelium surface that displayed beating 
cilia at each time point (Figure 3D). In noninfected HAE, approx-
imately 90% of the epithelium surface possessed active cilia, and 
this level was maintained over 6 consecutive days of analysis. A 
similar extent of cilia activity was measured during the first 2 days 
of RSV infection, indicating that cilia activity of infected cells was 
not significantly affected early during infection, similar to our 
previous findings (14). However, beginning at day 3 pi, the area 
of active cilia progressively declined, resulting in only 38% of the 
epithelium surface displaying active cilia by day 5 pi and 10% by 
day 6 pi. These results suggest that RSV infection has little effect 
on the ability of the ciliated epithelium to generate MCT within 
the first few days of infection. However, as the numbers of infected 
cells increased and as infection of individual cells resulted in api-
cal membrane cytopathology, RSV infection can abolish MCT. 
We noted that at day 3 pi and day 4 pi, although the area of cilia 
activity was high, MCT rates had rapidly declined. Such declines in 
MCT rate prior to significant losses in the area of active cilia may 
be explained by subtle but deleterious effects of RSV infection on 
coordinated cilia beat, such as cilia beat asynchrony and subse-
quent disruption of unidirectional transport. Indeed, high-speed 
video images of RSV-infected ciliated cells reveal visual evidence of 
cilia beat asynchrony prior to the loss of cilia structures (Supple-
mental Figure 1 and Supplemental Video 1; supplemental material 
available online with this article; doi:10.1172/JCI72948DS1). 
Taken together, these data suggest that, at least until day 3 pi, 
RSV-infected HAE cultures maintain sufficient MCT to transport 
infected cells shed across the airway surface, and that cell shedding 
may represent a previously unidentified mechanism to enhance 
MCT-mediated clearance of RSV infection from the airways.
Cell rounding is unique to RSV among a number of common paramyxo-
viruses. We also investigated whether RSV-induced rounding of cili-
ated cells occurred following infection with other respiratory viruses 
known to infect ciliated cells in HAE. Ciliated cells infected by PIV 
serotypes 1, 2, 3, or 5, Sendai virus (SeV), or human metapneu-
movirus (HMPV) failed to exhibit ciliated cell rounding (Figure 4, 
A and C, and data not shown). As an index of cell rounding, we 
measured the height of GFP-positive cells using confocal micros-
copy xz sections. Ciliated cells infected by RSV were significantly 
shorter, due to cell rounding, than those infected by the other GFP-
expressing respiratory viruses that were tested (Figure 4C). Our 
studies utilized a recombinant RSV A2 strain expressing GFP, and 
we confirmed that cell rounding was not an artifact of the recom-
binant virus or expression of GFP, as a recombinant RSV without 
GFP (GP1), the biologically derived RSV from which the recom-
binant was generated (HEp-4), and a wild-type RSV strain of sub-
group B all caused rounding of infected ciliated cells identical to 
the recombinant GFP-expressing virus (data not shown). Because 
studies have described phenotypic differences between highly pas-
saged RSV strains and clinical isolates, we confirmed that a recently 
isolated, minimally passaged, clinical strain of RSV (RSV Mem-
phis 37) caused infected ciliated cells to round with morphology 
indistinguishable from those cells infected by recombinant GFP-
expressing RSV (Figure 4A). Overall, these data suggest that ciliated 
cell rounding is a unique consequence of RSV infection.
Columnar cell rounding is associated with expression of the NS2 gene. 
We speculated that the unique morphologic phenotype induced 
in ciliated cells by RSV infection might be due to the expression 
of specific RSV genes. We explored this possibility by infecting 
human ciliated cells with recombinant, GFP-expressing RSVs 
Figure 4
RSV-induced ciliated cell rounding is unique to RSV infection and is 
due to expression of the RSV NS2 protein. (A) Representative images 
of histologic cross-sections of fixed and paraffin-embedded HAE 
infected with recombinant RSV-GFP, low-passage clinical isolate RSV 
Memphis 37, or recombinant PIV3-GFP. Infected cells were detected at 
day 3 pi using an anti-RSV antibody or anti-PIV3 antibody, as appropri-
ate. Scale bar: 10 μm. (B) Representative images of histologic cross-
sections of HAE infected with RSV, or gene deletion mutants RSVΔNS1 
and RSVΔNS2. All viruses express GFP. (C and D) Height of infected 
ciliated cells (mean ± SD) was determined using confocal microscopy 
of fixed but unprocessed HAE infected with RSV, PIV3, HMPV, PIV5, 
or SeV or the RSV gene deletion mutants RSVΔNS1, RSVΔNS2, and 
RSVΔNS1/2. All viruses expressed GFP. At least 100 infected cells in 
cultures obtained from 3 different donors were measured. *P < 0.05, 
**P < 0.01, ***P < 0.001, 1-way ANOVA with Tukey’s post-hoc test.
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from which individual viral genes had been deleted. These stud-
ies revealed that infection of ciliated cells by a mutant RSV with 
deletion of the two NS genes, NS1 and NS2 (RSVΔNS1/2), failed 
to cause rounding of infected ciliated cells (Figure 4D). Instead, 
ciliated cells infected with this mutant retained the native colum-
nar morphology and resembled the morphology of ciliated cells 
infected by other respiratory viruses, such as PIV3. Evaluation 
of RSV mutants deleted of NS1 or NS2 genes (RSVΔNS1 and 
RSVΔNS2) showed that RSVΔNS1 induced ciliated cell rounding 
indistinguishable from that of RSV expressing a full complement 
of RSV genes, suggesting that NS1 was not responsible for the 
cell-rounding phenotype (Figure 4, B and D). In contrast, ciliated 
cells infected by RSVΔNS2 did not round and maintained colum-
nar morphology identical to that following RSVΔNS1/2 infection 
(Figure 4, B and D). These differential effects of the NS-deleted 
viruses were not due to significant differences in mutant virus 
replication, as both RSVΔNS1 and RSVΔNS2 were similarly atten-
uated for replication compared with RSV in cell lines (19) and 
HAE (Supplemental Figure 2A). Overall, these experiments indi-
cate that expression of NS2, in the context of RSV infection, is 
necessary for RSV-induced ciliated cell rounding.
Expression of NS2 by recombinant PIV3 mimics RSV-induced cell 
morphology. Since PIV3, like RSV, exclusively infects ciliated cells 
in HAE cultures but does not cause rounding of ciliated cells, we 
used recombinant PIV3 to deliver RSV NS1, NS2, or both genes 
to ciliated cells in the absence of other RSV genes. Recombinant 
PIV3 was engineered to express GFP and NS2 (PIV3-NS2), NS1 
(PIV3-NS1), or both NS1 and NS2 (PIV3-NS1/2), and the conse-
quences of infection compared with PIV3 expressing GFP alone 
were assessed. In each case, GFP was inserted between the P and 
M genes, and the RSV gene(s) were inserted between the HN and 
L genes. All recombinants were readily recovered, and infection 
and growth were assessed in non-polarized epithelial cell lines 
and HAE cultures. In non-polarized epithelial cell lines, recombi-
nant PIV3 viruses expressing RSV NS genes and GFP were slightly 
attenuated for growth compared with PIV3 expressing GFP alone 
(Supplemental Figure 2, B and C). Similar to cell lines, in HAE, all 
3 PIV3 viruses expressing RSV NS genes exhibited modest growth 
attenuation compared with PIV3, despite similar levels of infec-
tion at day 1 pi (Figure 5A). Growth of PIV3-NS2 and PIV3-NS1 
was equally attenuated in HAE, replicating to titers approximately 
1 log lower than PIV3 at day 3 pi, the time of peak replication. 
Growth of PIV3-NS1/2 was more severely attenuated, producing 
titers 2 logs lower than PIV3 at the time of peak replication. This 
observed attenuation presumably reflected the increased genome 
length and gene number of the PIV3 viruses with inserted RSV NS 
genes, although the possibility exists that the RSV NS proteins had 
direct inhibitory effects on replication.
In HAE cultures, ciliated cells infected by PIV3 or PIV3-NS1 
maintained native columnar morphology, whereas ciliated cells 
infected by PIV3-NS2 or PIV3-NS1/2 underwent cell rounding, 
with significantly shortened cell heights (Figure 5, B and C) and 
closely resembled ciliated cell morphology after RSV infection. 
The observation that PIV3-NS1/2 and PIV3-NS2 caused cell 
rounding indistinguishable from that caused by RSV suggested 
that NS2 mediated this effect independent of the expression of 
NS1 or other RSV proteins.
NS2 expression adversely affects ciliated cell structure and function. In 
addition to similar overall morphology of ciliated cells infected by 
PIV3-NS2 and RSV, closer examination of ultrastructural features 
of the apical surfaces of ciliated cells infected by PIV3-NS2 or PIV3- 
NS1/2 recapitulated those of RSV-infected cells. Characteristics 
of RSV-infected ciliated cells such as bulging apical membranes, 
thinning of the terminal web, and loss of cilia and microvilli were 
evident in, and indistinguishable between, ciliated cells infected by 
RSV, PIV3-NS2, and PIV3-NS1/2 (Figure 6A).
Functional studies measuring the extent of cilia activity in 
HAE infected by the recombinant viruses demonstrated that 
PIV3-NS2 and PIV3-NS1/2 infection resulted in a marked 
decline in the surface area of epithelium displaying cilia activity 
within the first 4 days of infection (Figure 6B). In contrast, PIV3 
infection did not affect the extent of cilia activity until day 5 
pi. PIV3-NS1, despite robust infection, had little effect on cilia 
activity within the 6 days of experimental analysis. These data 
suggest that PIV3 infection was less cytopathic to cilia activity 
compared with PIV3-NS2, indicating that NS2-promoted cell 
rounding may also be associated with disruption of cilia or cilia 
scaffolding complexes in infected cells. We also noted that NS1 
may further reduce the moderate cytopathology evident after 
PIV3 infection. These findings are intriguing, as they point to 
divergent effects of RSV NS1 and NS2 on ciliated cell cytopa-
thology. However, as noted above, experiments with PIV3-NS1/2 
indicate these divergent effects of NS2 and NS1 expression on 
Figure 5
Expression of RSV NS2 in ciliated cells using PIV3 results in infected 
cell rounding. (A) Growth kinetics of recombinant PIV3 (white circles) 
and PIV3 expressing either RSV NS1 (PIV3-NS1, black squares), 
NS2 (PIV3-NS2, white triangles) or both NS1 and NS2 (PIV3-NS1/2, 
black triangles) in HAE. All viruses expressed GFP. Virus titers in api-
cal washes were assessed at 24-hour intervals. Data (mean ± SEM) 
represent 4 cultures per donor with cultures from 3 different donors. 
(B) Representative images of histologic cross-sections of HAE infected 
with PIV3, PIV3-NS1, PIV3-NS2, or PIV3-NS1/2. Infected cells were 
detected with an anti-PIV3 antibody. Scale bar: 10 μm. (C) Height of 
infected cells (mean ± SD) was determined as described in Figure 4. 
*P < 0.05, **P < 0.01, 1-way ANOVA with Tukey’s post-hoc test.
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ciliated cell cytopathology are dominated by the effects of NS2 
when both NS proteins are expressed together, as occurs with 
PIV3-NS1/2 or RSV infection.
Effects of RSV NS2 on PIV infection of airway epithelium in vivo. We next 
used the PIV3 viruses expressing RSV NS genes to test the morpho-
logic consequences of RSV NS2 expression in vivo. Because PIV3 
poorly infects the airway epithelium of mice, we chose Golden Syr-
ian hamsters as our in vivo model, as they are a well-documented 
useful model of PIV3 airway infection (20). We first focused on the 
hamster nasal respiratory airway epithelium, as this pseudostrat-
ified columnar epithelium contains ciliated and mucin-contain-
ing (goblet) cells at densities similar to those of columnar cells in 
HAE cultures and human cartilaginous airway epithelium in vivo. 
Hamsters were inoculated intranasally with PIV3, PIV3-NS2, or 
PIV3-NS1 (106 PFU). Maximal virus titers were reached in the nasal 
tissue by day 3 pi, and we observed equal but modest attenuation of 
growth of PIV3-NS1 and PIV3-NS2 compared with PIV3 (Figure 7A), 
similar to attenuation in HAE (Figure 5A).
Identification of virus-infected epithelial cells by immunodetec-
tion of PIV3 antigen in histologic sections of hamster nasal epithe-
lium at day 3 pi showed that all recombinant PIV3 viruses infected 
ciliated columnar cells but not mucin-containing Goblet colum-
nar cells of the hamster nasal respiratory epithelium (Figure 7B). 
While ciliated cells infected by PIV3 or PIV3-NS1 retained the 
native columnar cell morphology, cells infected by PIV3-NS2 
exhibited rounded cell morphology and resembled human ciliated 
cells infected by PIV3-NS2 or RSV in vitro. Morphometric analysis 
of infected ciliated cell height in histologic sections of hamster 
nasal respiratory epithelium revealed a significant shortening of 
ciliated cells infected by PIV3-NS2 compared with those infected 
by PIV3 or PIV3-NS1 (Figure 7C), reproducing the phenotype seen 
in HAE (Figure 5B). In PIV3-NS2–infected hamster nasal cavi-
ties, virus antigen–positive cells were occasionally observed while 
shedding from the epithelium into the airway lumen, but unlike 
what was observed in HAE, accumulations of shed, virus-infected 
epithelial cells after PIV3-NS2 infection were rarely noted in the 
nasal cavity, suggesting that epithelial cells shed from the epithe-
lium were rapidly cleared from the airway lumen, presumably by 
mechanical clearance mechanisms.
Next we compared the consequences of PIV3 and PIV3-NS2 
infection in the lungs of hamsters. Because PIV3-NS1 infection 
did not induce ciliated cell rounding in HAE or hamster nasal epi-
thelium, we focused our lower airway studies on the comparison of 
PIV3 versus PIV3-NS2 infection. In hamsters inoculated with PIV3, 
histologic analysis of whole lungs after day 3 pi showed viral anti-
gen distributed throughout the conducting airway epithelium of 
the large bronchial and small bronchiolar airway regions (Figure 8, 
A and B, respectively). Although virus antigen was occasionally 
detected in cells of the alveolar regions, the majority of infected 
cells were restricted to the conducting airways. PIV3-infected epi-
thelial cells of both large and small airways retained columnar 
morphology and remained embedded in the epithelium, similar 
to PIV3-infected epithelial cells in HAE cultures.
In contrast, in hamsters infected by PIV3-NS2 for 3 days, all virus 
antigen–positive cells in the larger-diameter airways were rounded 
and either shedding from or fully detached from the underlying 
intact epithelium (Figure 8A). The smaller-diameter bronchiolar 
airways similarly showed extensive rounding and detachment of 
epithelial cells infected by PIV3-NS2 (Figure 8B). Remarkably, 
the bronchiolar airway lumens contained accumulations of shed, 
virus antigen–positive cells (Figure 8B), the extent of which was 
sufficient to cause partial to complete occlusion of the bronchio-
lar airway lumens (Figure 8C). Although shed cell accumulation 
in bronchioles was dramatic at day 3 pi, it was also transient, and 
by day 5 pi almost all evidence of bronchiolar airway occlusion 
and infection was absent, suggesting that the cell accumulations 
were effectively cleared from the airway lumens (Figure 8B). The 
rapid clearance of virus-infected cells from within the bronchio-
lar airway lumen was also noted in the bronchial airways at day 
5 pi (Figure 8A). In contrast to the consequences of PIV3-NS2 
Figure 6
Expression of RSV NS2 by PIV3 in HAE cultures mimics RSV-induced 
cytopathology at the apical surface of ciliated cells. (A) Representa-
tive images of histologic sections of noninfected HAE, or HAE infected 
by RSV, PIV3, PIV3-NS1, PIV3-NS2, or PIV3-NS1/2 fixed at day 2 pi 
showing similar apical membrane disruption in ciliated cells infected by 
RSV, PIV3-NS2, and PIV3-NS1/2. Richardson’s counterstain was used. 
Scale bar: 10 μm. (B) Surface area of active cilia beat on noninfected 
HAE (black circles, dotted line) or HAE infected with PIV3 (white cir-
cles), PIV3-NS1 (black squares), PIV3-NS2 (white triangles), or PIV3- 
NS1/2 (black triangles). Data (mean ± SEM) represent quadruplicate 
cultures. All viruses expressed GFP.
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infection, the robust PIV3 infection of the bronchial and bron-
chiolar airway epithelium at day 3 pi remained largely unaltered 
by day 5 pi, indicating that PIV3-infected cells were not cleared 
from the epithelium as effectively as those infected by PIV3- 
NS2 (Figure 8, A and B).
To determine whether the more effective clearance of virus-in-
fected cells following PIV3-NS2 infection influenced viral load 
in the lung, we harvested hamster lung tissues inoculated with 
PIV3-NS2 or PIV3 at days 1, 2, 3, 5, and 7 pi and measured whole 
lung virus titers. These data revealed a strong temporal correlation 
between the extent of virus antigen–positive cells and lung viral 
titers. Specifically, although PIV3 and PIV3-NS2 titers were similar 
at days 1 and 2 pi, PIV3 titers declined by less than 1 log between 
days 3 and 5 pi, whereas during the same time period PIV3- 
NS2 titers rapidly fell by almost 3 logs (Figure 8D). Infection by 
both viruses was completely cleared from the lungs by day 7 pi. 
Throughout the experiments, hamsters showed no clinical signs 
of illness, as reported in previous studies of PIV3 infection of ham-
ster airways (20). This is not surprising given the semi-permissive 
nature of PIV3 infection in this non-native host.
In contrast to HAE and hamster nasal epithelium studies in 
which PIV3 only infected ciliated cells, we noted that PIV3 and 
PIV3-NS2 infected both ciliated and non-ciliated columnar cells 
in the lower airways. We also noted that PIV3-NS2–infected cells 
shed into the small airways exhibited an unusual pleomorphic 
morphology compared with cells shed from HAE or the hamster 
nasal respiratory epithelium. Shed PIV3-NS2–infected lower air-
way cells were swollen and at times bi-nucleated, with cell bod-
ies protruding from the intact epithelium into the airway lumen 
(Figure 9A). Using cytokeratin 18 as an immunomarker for epithe-
lial cells, we confirmed that the infected, shedding, and accumu-
lated cells were epithelial cells, as expected (Figure 9A).
To ascertain whether the morphologic consequences of PIV3- 
NS2 infection of hamster lower airways resembled those in lower 
airways of humans infected by RSV, we probed histologic sections 
of autopsy lung tissues obtained from RSV-infected patients for 
viral antigen. Assessment of pseudostratified columnar airway epi-
thelium, indicative of larger airway regions, showed clear evidence 
of RSV antigen–positive epithelial cells embedded in the epithe-
lium, displaying shortened, rounded cell morphology (Supple-
mental Figure 3B). Occasionally, RSV antigen–positive cells were 
also detected detached in the airway lumen, suggestive of shed, 
virus-infected cells that had not fully cleared from the airway. 
Examination of the distal bronchiolar airways revealed bronchi-
olar lumens partially or fully occluded by pleomorphic epithelial 
cells positive for RSV antigen and in some cases in the process of 
shedding into the airway lumen (Figure 9B, Supplemental Figure 
3A). Swollen and bi-nucleated cells were also observed in the air-
way lumen of these regions. These observations indicated that the 
morphologic changes, cell shedding, and small airway occlusions 
observed in hamster distal airways infected by PIV3-NS2 resem-
bled the consequences of RSV infection of human lower airways 
detected in postmortem samples.
Discussion
RSV is the most important viral agent of lower airway disease 
in infants and young children and is commonly associated with 
severe bronchiolitis in these populations. In infants, bronchiolitis 
caused by RSV is documented to be more severe and prolonged 
than bronchiolitis caused by other etiologies, including PIVs or 
rhinoviruses (21, 22). A recent study of young children with acute 
respiratory illness found that those infected with RSV had twice 
as many emergency room visits and 6 times more hospitalizations 
than those with seasonal influenza virus infections (23). The rea-
sons why RSV has a tendency toward increased frequency and 
severity of distal small airway disease in infants compared with 
other etiologies are unknown.
In vitro and in vivo studies have established that ciliated cells of 
the human large cartilaginous airways are important targets for 
RSV infection. The ciliated airway epithelium serves an impor-
tant role in maintaining lung health, as it provides a mechanical 
barrier against inhaled pathogens and contributes to clearance by 
facilitating MCT. Precisely how RSV infection of the airway epi-
thelium leads to airway disease is poorly defined, but has been 
attributed to both direct virus-mediated epithelial cell cytopathol-
ogy and exaggerated host immunopathology, especially excessive 
neutrophil-associated inflammation (24). Other consequences of 
RSV infection, such as incidence of wheezing and possible skewing 
of future immune responses, have been reported (25, 26). Clinical 
and preclinical studies have greatly increased our understanding 
of RSV pathogenesis, but the early initiating aspects of RSV infec-
tion of the airway epithelium and the relationship to subsequent 
airway pathology remain poorly defined.
Figure 7
PIV3-NS2 causes ciliated cell rounding in the hamster nasal respira-
tory epithelium in vivo. (A) The nasal epithelium of Golden Syrian ham-
sters was inoculated with 106 PFU of PIV3 (black circles), PIV3-NS1 
(white squares), or PIV3-NS2 (black triangles), and virus titers in the 
nasal turbinates were determined at day 3 pi. Data (mean ± SEM) 
represent 3 independent experiments with a total of 9 to 12 animals. 
(B) Representative images of histologic cross-sections of hamster 
nasal respiratory epithelium infected with PIV3 (top), PIV3-NS1 (cen-
ter), or PIV3-NS2 (bottom). Virus antigen was detected at day 3 pi with 
an anti-PIV3 antibody. Scale bar: 10 μm. (C) Height of infected ciliated 
cells (mean ± SD) was determined by measuring height of virus anti-
gen–positive cells from fixed tissue sections, with at least 200 cells 
analyzed across 3 individual animals. All viruses expressed GFP. 
***P < 0.001, 1-way ANOVA with Tukey’s post-hoc test.
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Investigating the role of the airway epithelium in RSV patho-
genesis has been impeded by the scarcity of representative models 
of polarized and differentiated airway epithelium that are both 
susceptible to human RSV infection and mimic the outcomes 
of infection observed in RSV-infected human airways in vivo. 
Indeed, most experiments modeling RSV infection of the air-
way epithelium rely on transformed, non-polarized epithelial 
cell lines, which do not resemble the differentiated architecture 
of airway epithelium in vivo. The widely available in vivo mod-
els, particularly small rodents, also poorly reproduce the conse-
quences of RSV infection observed in human airways, largely due 
to low infectivity of the conducting airway epithelium by RSV. 
Species-specific RSV equivalents used in appropriate permissive 
hosts, such as bovine RSV in calves, are useful models for under-
standing RSV pathogenesis, but differences between the human 
and animal viruses and the human and animal hosts have been 
documented and can complicate such analyses (27).
In the present study, we combined in vitro and in vivo models 
of differentiated airway epithelium to assess the impact of RSV 
infection on the integrity and function of the ciliated airway epi-
thelium. Using cultures of primary pseudostratified HAE cells 
that closely resembled the epithelium of authentic airway tissue, 
we showed that RSV infection of human ciliated cells resulted in 
the development of a rounded cell morphology and distinct apical 
surface cytopathology, followed by extrusion of the infected cells 
from the epithelium. These effects were not observed in ciliated 
cells infected by PIV3 or several other respiratory paramyxoviruses. 
Once infected ciliated cells shed from the epithelium, these cells 
were incorporated into mucus secretions and underwent cell 
death. The shed cells and associated mucus secretions were trans-
ported across the airway surface by coordinated cilia beat.
The use of RSV gene-deletion mutants revealed that these 
effects were due to expression of the RSV NS2 protein. Specif-
ically, whereas ciliated cells infected by RSV became rounded, 
ciliated cells infected with RSVΔNS2 maintained columnar mor-
phology and remained embedded within the intact epithelium. 
Because PIV3 also targeted ciliated cells but did not cause the cell 
rounding phenotype, we used PIV3 as a vector to express RSV 
genes in ciliated cells. This novel approach to study virus gene 
expression in ciliated cells demonstrated that RSV NS2 expressed 
Figure 8
Distal airway obstruction and accelerated clearance of virus infection in hamsters infected by PIV3-NS2. (A and B) Representative images of 
histologic cross sections of hamster large airways (A) and small airways (B) 3 days and 5 days after infection with PIV3 or PIV3-NS2. Note the 
rapid loss of PIV3-NS2–infected cells from airways at 5 days pi, a time when PIV3 infection remained robust. Scale bar: 100 μm. (C) Morphomet-
ric quantitative analysis of distal airway cell accumulation in hamsters infected with PIV3 or PIV3-NS2 by measuring the percentage of cross-
sectional airway lumen surface area occupied by virus antigen–positive cells at day 3 pi. Histologic, antigen-stained whole lung sections from 
6 animals were measured. Each column represents an individual animal, and each symbol represents occlusion of an individual airway. Statistical 
analysis of the mean occlusion values of the two groups was used to determine significance. P < 0.01, Mann-Whitney U test. (D) Whole lung virus 
loads in hamsters infected with PIV3 (black circles) or PIV3-NS2 (white squares) measured over time, demonstrating a more rapid clearance of 
PIV3 infection when the virus expressed RSV NS2. Data (mean ± SEM) represent 3 independent experiments with a total of 4 to 9 animals per 
time point. All viruses expressed GFP. ***P < 0.0001, unpaired t test.
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by PIV3 caused morphologic changes in infected ciliated cells 
indistinguishable from those infected by RSV. Taken together, 
these findings identify expression of RSV NS2, in the context 
of either RSV or PIV3 infection, as sufficient to induce rounded 
morphology in ciliated cells.
We used PIV3-NS2 and control viruses to investigate the signif-
icance of these findings in vivo using the hamster model. In the 
hamster nasal cavity, PIV3 recombinant viruses infected only cili-
ated cells of the respiratory epithelium, and only PIV3-NS2 caused 
ciliated cell rounding, membrane cytopathology, and cell extrusion, 
similar to our findings in HAE after RSV or PIV3-NS2 infection.
Infection of the hamster lower airway epithelium with PIV3- 
NS2, but not PIV3, also resulted in rounding and shedding of 
the infected cells from the epithelium into the airway lumen. In 
the large airways of hamsters infected with PIV3-NS2, infected 
cells shed from the epithelium rarely accumulated in the airway 
lumen, suggesting that the majority of shed cells were rapidly 
and effectively cleared from the lumen, presumably by mechan-
ical airway clearance mechanisms. In the smaller-diameter air-
ways, shed cells accumulated in the airway lumen, suggesting 
that clearance of shed cells from the small airway lumens was less 
efficient compared with clearance from the larger airways. These 
effects were most pronounced in the small airways of hamsters 
2 to 3 days after infection by PIV3-NS2, and accumulations of 
detached virus antigen–positive cells were easily detected occlud-
ing the small airway lumens, reminiscent of bronchiolar airway 
occlusions observed in the small airways of young 
infants infected by RSV. We also note that studies 
with RSV-infected infants have described infection 
of the larger airways as patches or clusters of infected 
cells, compared with more robust circumferential 
infection reported in the distal airway epithelium 
(10, 28). Our in vivo studies with PIV3-NS2 suggest 
that patchy infection in large airways may represent 
continuous shedding and clearance of infected cells 
in these regions, while shedding and accumulation 
may perpetuate infection in the distal airways.
The combination of small-diameter airway lumens 
and the swollen volume of shed cells in the distal 
airway regions of hamsters after PIV3-NS2 infec-
tion likely contributes to the development of air-
way occlusion. This finding has clear implications 
for RSV infection of human infants, where the very 
narrow distal airway lumens of the still-developing 
infant lung have been proposed to increase vulner-
ability of the distal airway regions to obstruction 
(29). We did note in our studies that cells shedding 
into the hamster lower airways were pleomorphic 
and unusually swollen compared with cells shedding 
from HAE or into the hamster nasal respiratory epi-
thelium. The differences in morphology and size of 
shed cells following PIV3-NS2 infection may reflect 
differences in the responses of epithelial cells distrib-
uted in the lower versus upper airways. Alternatively, 
the swollen pleomorphic cells in lower airways may 
represent other epithelial cell types present in the 
lower but not upper airways, which, when infected by 
PIV3-NS2, respond differently to infection compared 
with ciliated cells. A potential candidate for such a 
cell type is the non-ciliated columnar club (Clara) 
cell. While club cells are rarely present in the nasal epithelium, 
they are present in hamster and human lower airways, with club 
cell density increasing as airways descend into the distal bronchi-
olar airway regions (30, 31). Indeed, while only ciliated cells of the 
nasal respiratory epithelium were infected by PIV3 and PIV3-NS2, 
in the lower airways, both ciliated and club cells were infected by 
these viruses. RSV also infects both ciliated and non-ciliated cells 
of the lower airways of humans (10, 12), and both cell types are 
infected in the small airways of calves and lambs experimentally 
infected with RSV (32, 33). Thus, the differences in morphology 
between cells shed into the lower versus upper airways might be 
due to PIV3-NS2 infection of club cells. Regardless of the specific 
epithelial cell types infected by PIV3-NS2 in the different airway 
regions, we suggest that the combination of smaller diameter of 
airway lumens in the bronchioles and the expanded volume of 
cells shed into these airway regions enhances the likelihood that 
shed cells would accumulate in and occlude distal airways.
Unusual epithelial cell morphology has been described for 
RSV-infected humans and bovine RSV–infected calves (11, 12, 32), 
and sloughing of virus antigen–positive cells caused small airway 
occlusion in ovine and baboon models of RSV infection (33–35). 
The loss of cilia and disorganization of cilia basal bodies noted 
in human ciliated cells infected by RSV and PIV3-NS2 was also 
reported in a bovine model of RSV infection (32). Ciliary dyski-
nesia and apical membrane damage have been reported in RSV- 
infected human ciliated airway epithelium cultures (36). Thus, in 
Figure 9
Shed epithelial cells infected by PIV3-NS2 into hamster lower conducting airways 
resembles shed epithelial cells in RSV-infected human infants. (A) Representative 
images from histologic cross sections of hamster distal airways infected with PIV3 
and PIV3-NS2. Sections were stained with H&E, or with antibody against PIV3 to 
identify PIV3-infected cells, or with an antibody against cytokeratin 18 (CK18) to 
identify epithelial cells at day 3 pi. Scale bar: 50 μm. (B) Sample images of histologic 
cross sections of human lower airways obtained postmortem from a patient naturally 
infected by RSV. Sections were stained with H&E, or with an RSV-specific antibody 
to detect infected cells, or with a CK8/18 antibody to detect epithelial cells. Scale bar: 
50 μm. The smaller-diameter distal airways of both hamster and human demonstrate 
virus antigen–positive cells that have shed and accumulated in the lumen, often suf-
ficient to have caused airway occlusion.
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several appropriate animal models of RSV infection as well as ret-
rospective analysis of human cases of RSV infection, shedding of 
pleomorphic, virus antigen–positive epithelial cells, especially in 
the smaller-diameter distal airways, appears to be a characteristic 
hallmark of RSV infection. We propose that RSV NS2 may be a 
major contributor to the development of these early pathologic 
findings following RSV infection.
Accumulation of shed cells in the distal lower airways of ham-
sters infected with PIV3-NS2 suggests that RSV NS2–induced 
cell shedding might have importance for the initiation of RSV- 
associated disease. RSV bronchiolitis is closely associated with 
small airway obstruction, resulting in air trapping distal to the 
obstruction and increased airway resistance (37, 38). Classically, 
the obstructive material has been considered to be a mixture of 
necrotic epithelial cells, mucus secretions, and inflammatory 
cell exudate. However, autopsy specimens from RSV-infected 
patients, including those described in this study, rarely show the 
presence of mucus plugs in the small airways but consistently 
show unusual pleomorphic epithelial cells positive for virus anti-
gen in the airway lumen. These human autopsy specimens from 
patients infected with RSV combined with hamsters infected by 
PIV3-NS2 emphasize the potential significance of shed and accu-
mulated epithelial cells as major contributors to small airway 
obstruction following RSV infection.
The present study suggests that RSV has an unusual and per-
haps unique ability to induce epithelial cell shedding, and that 
NS2-induced cell shedding may be an important factor in RSV 
pathogenesis. However, the dramatic distal airway plugging in 
PIV3-NS2–infected hamsters was transient, as maximal occlusion 
occurred at day 3 pi but was cleared by day 5 pi. Obstruction of 
small airways was also not associated with increased clinical dis-
ease in hamsters. The lack of disease associated with PIV3 (and 
RSV) infection in rodent models likely reflects their semi-permis-
sive nature for virus replication, with relatively low whole lung viral 
titers and relatively short durations of infection. In contrast, RSV 
infection of humans results in substantially higher virus titers, 
and virus shedding can continue for up to several weeks (39, 40). 
Primary RSV infection in humans is nearly always symptomatic, 
and in this more permissive setting, it is reasonable to expect that 
RSV NS2–promoted obstruction of small airways with shed epi-
thelial cells would be longer lived, promoting enhanced infection 
and inflammation and contributing to increased disease severity. 
Interestingly, we also noted that PIV3-NS2 infection was cleared 
from hamster lungs more rapidly than was PIV3. This was evident 
by histologic analysis, which showed that despite the extensive 
infection and airway occlusions associated with PIV3-NS2 on day 
3 pi, the infected cells were largely cleared by day 5 pi. In contrast, 
in animals infected with PIV3, there were abundant infected cells 
on both days 3 and 5 pi. Consistent with this, quantification of 
whole lung viral titers confirmed that PIV3-NS2 was cleared more 
rapidly than PIV3, even though both viruses reached similar peak 
titers by days 2–3 pi.
Previous studies have demonstrated that the RSV NS proteins 
enhance viral replication. Recombinant RSV deleted for 1 or both 
NS genes resulted in viruses with severely attenuated growth in 
vitro and in vivo (41–43). Deletion of either the NS1 or NS2 gene 
attenuated human RSV in chimpanzees (42, 44). The NS pro-
teins have also been shown to interfere with a number of antiviral 
host responses aimed at reducing the extent of virus replication, 
most notably types I and III IFN pathways. The mechanisms by 
which NS1 and NS2 inhibit IFN responses are complex, involving 
both coordinated and independent functions of the NS proteins 
(41, 45–48). Both proteins have also been implicated in inhibiting 
apoptosis (49), and RSV NS2 was reported to enhance induction 
of NF-κB (19). Although some effects of the NS proteins appear 
to involve synergy between NS1 and NS2, this did not appear to 
be the case in the present study. Here, the morphologic and shed-
ding phenotype attributed to RSV NS2 appeared to be indepen-
dent of, and unaffected by, NS1. While the precise mechanism of 
NS2-induced morphologic consequences remains unknown, we 
speculate that these events are not directly related to the ability of 
NS2 to modify IFN responses.
The mechanism by which RSV NS2 exerts its effects on epithe-
lial cell rounding and shedding remains to be explored. Based on 
changes in columnar cell morphology, it would be reasonable to 
speculate that RSV NS2 may exert effects on cytoskeletal struc-
tures. Indeed, RSV has been reported to have effects on interme-
diate filaments and actin filament structures (50–53). The influ-
ence of RSV NS2 on cytoskeletal elements represents a potential 
mechanism for cell rounding following RSV infection and will be 
the focus of future studies. Comparison of PIV3-NS2 infection of 
epithelial cell line monolayers with PIV3 or PIV3-NS1 have thus 
far failed to reveal a morphologic phenotype attributable to RSV 
NS2 (data not shown), suggesting that the differentiated state of 
the columnar airway epithelial cells may be a critical component 
of NS2-induced cell rounding. The use of differentiated airway 
models such as HAE will therefore be important for understand-
ing how RSV NS2 modifies airway epithelial cells, resulting in the 
shedding of infected cells into the airway lumen.
In summary, we present evidence that infection of ciliated cells 
in HAE by RSV results in cell rounding, disruption of the cilia 
apparatus, active shedding of individual infected cells, and delay 
of cell death until infected cells are shed from the epithelium. By 
performing loss-of-function and gain-of-function experiments, 
we attribute these consequences of infection to the RSV NS2 
protein. Using PIV3 as a vector for RSV NS2, we confirmed these 
findings in an in vivo hamster model of infection. Expression 
of RSV NS2 in vivo resulted in accelerated clearance of infec-
tion, and we propose that NS2-induced cell shedding acts as a 
novel clearance mechanism to remove infected cells from both 
the airway epithelium and the lumen. In the smaller-diameter 
distal airways, however, NS2-induced shedding contributed to 
acute airway obstruction, which was strikingly reminiscent of 
the airway plugging that occurs during RSV bronchiolitis in 
infants. Although other respiratory viruses also cause bronchi-
olitis in young children, we suggest that NS2-mediated cell shed-
ding and subsequent airway obstruction may contribute to the 
increased incidence and severity of RSV-associated bronchiolitis 
compared with other viral etiologies. The notion that RSV NS2 
may be a pathogenesis factor increasing the likelihood of small 
airway obstruction as a precursor to bronchiolitis identifies NS2 
as a potential therapeutic target for limiting the severity and fre-
quency of RSV bronchiolitis, particularly in infants. It also sug-
gests that deletion of the NS2 gene may be desirable in live-at-
tenuated RSV vaccine candidates (54). Future studies are needed 
to explore whether RSV NS2–mediated shedding of infected 
cells affects the development of immunity to RSV infection, and 
whether manipulation of NS2-promoted epithelial cell shedding 
may serve as a therapeutic target for reducing the severity of dis-
tal airway disease in RSV-infected infants.
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Methods
Cells
HAE cells were isolated by the University of North Carolina Cystic Fibrosis 
Center Cell Culture and Tissue Procurement Core from tracheobronchial 
airway specimens obtained from patients, provided by the National Disease 
Research Interchange or as excess tissue following lung transplantation. All 
protocols were approved by the University of North Carolina at Chapel Hill 
Institutional Review Board. Primary epithelial cells derived from single 
patient sources were plated on permeable Transwell-Col supports (12-mm 
diameter; Corning Inc.) and grown in custom media at an air-liquid inter-
face for 8 to 10 weeks to form differentiated, polarized cultures as previously 
described (55). HEp2 cells (ATCC) were maintain in MEM (Gibco) supple-
mented with 10% fetal bovine serum (Foundation; Gemini Bio-Products). 
LLC-MK2 cells (ATCC) were maintained in DMEM (Gibco) supplemented 
with 10% fetal bovine serum (Foundation; Gemini Bio-Products).
Animals
In vivo animal studies used Golden Syrian hamsters (Harlan), and all 
procedures were conducted in accordance with the NIH Guide for the 
Care and Use of Laboratory Animals and using animal study protocols 
approved by the Animal Care and Use Committee of the National Institute 
of Allergy and Infectious Diseases and the Institutional Animal Care and 
Use Committee of the University of North Carolina at Chapel Hill.
Viruses
All viruses used in this study were derived from cDNA (recombinant) and 
contain a GFP insertion as an additional gene, unless otherwise mentioned.
Recombinant HMPV (strain CAN97-83), PIV5 (strain W3A; provided by 
Robert Lamb, Northwestern University, Evanston, Illinois, USA), and SeV 
(provided by Daniel Kolakofsky, University of Geneva School of Medicine, 
Geneva, Switzerland) were described previously (56–58). RSV Memphis 
37 strain was isolated from a pediatric case of bronchiolitis and has been 
described previously (39). This virus is a primary low-passage clinical iso-
late, not a recombinant virus, and does not express GFP.
Wild-type RSV, RSVΔNS1, RSVΔNS2, and RSVΔNS1/2 are derivatives of 
the A2 strain and were constructed and described previously (44, 59–61). 
Each of these RSV constructs express the GFP gene as an additional gene 
inserted between the RSV P and M genes. Wild-type RSV and all mutants 
were amplified in HEp2 cells stably expressing the V gene from SV5 (62). 
The SV5-V plasmid was provided by Richard Randall (University of St. 
Andrews, St. Andrews, United Kingdom).
PIV3 is a derivative of the JS strain engineered to express the GFP gene 
as an additional gene inserted between the PIV3 P and M genes, as has 
been described previously (63, 64). Codon-optimized RSV NS1 or NS2 
genes were synthesized (DNA2.0) and inserted into the PIV3 viral genome 
between the hemagglutinin-neuraminidase (HN) and viral polymerase 
(L) genes using cloning methods similar to those previously used to 
express CFTR and rhAFP in this genome region (65, 66). A unique EagI 
restriction site was generated in the non-coding region downstream 
of the HN gene in the PIV3 subgenomic cDNA. The NS1 or NS2 cod-
ing sequence was amplified using RT-PCR from plasmids expressing 
codon-optimized NS1 or NS2, cloned into a pCR-Blunt II-TOPO vector 
(Invitrogen) and sequenced. The following primer sets were used: NS1 
sense (5′-CCGCGGCCACCATGGGCAGCAATAGTCTC-3′), NS1 antisense 
(5′-GGGCCCGAGTTATGGGTTCAGGTCAA-3′), NS2 sense (5′-CCGC-
GGCCACAATGGATACCACGC-3′), and NS2 antisense (5′-GGGCCCCTC-
GAGTCAAGGGTTCAA-3′) (the underlined portions represent SacII and 
ApaI restriction sites). Using the SacII and ApaI restriction sites, NS1 or 
NS2 was inserted into a vector following a linker sequence consisting 
of the PIV3 gene-end, intergenic, and gene-start transcription regions, 
flanked at both ends by EagI sites. This cassette was then inserted using 
the EagI sites into the full-length PIV3GFP antigenomic cDNA, and the 
resulting genomes were designated PIV3-NS1 or PIV3-NS2. A PIV3 genome 
expressing both NS1 and NS2 was also generated by inserting the RSV 
NS1 and NS2 genes together into PIV3 between the HN and L genes using 
similar methods. From the linker vector containing NS1, a sequence 
consisting of the EagI restriction site, PIV3 linker region, and NS1 gene 
was PCR amplified using the NS1 sense primer (5′-CGAATTGGCGGC-
CGAAAATA-3′) and the NS1 antisense primer (5′-CAGGAGTTCAG-
CACGATGGGGGCCCGAGTTATGGGT-3′), destroying the 3′ EagI site 
and creating an 18-bp overhang. From the linker vector containing NS2, 
a sequence consisting of the PIV3 linker region, the NS2 gene, and the 
EagI restriction site was amplified using the NS2 sense primer (5′-GCT-
GAACTCCTGCATCGTAAAATAAGAAAAACTTAG-3′) and the NS2 anti-
sense primer (5′-ACTTGGCCCAAGCTTGAGTA-3′), destroying the 5′ EagI 
site and adding the complementary 18-bp overhang. These 2 fragments 
were combined in a fusion reaction using the NS1 sense and NS2 anti-
sense primers, and the resulting fragment was cloned into a pCRBluntII 
TOPO vector (Invitrogen) and sequenced. The final fragment consisted of 
a PIV3 linker region, the RSV NS1 gene, a second PIV3 linker region, and 
the RSV NS2 gene, flanked by EagI sites. This cassette was then inserted 
using the EagI sites into the full-length PIV3GFP antigenomic cDNA, cre-
ating PIV3-NS1/2. Each insert was designed to retain the “rule of 6,” in 
which a genome length with a multiple of 6 nucleotides is required for 
PIV3 genome replication. All viruses were rescued and amplified in LLC-
MK2 cells using methods described previously (63) and sequenced.
Viral inoculations and growth
In vitro studies. The apical surfaces of HAE were rinsed with PBS to remove 
excess airway secretions. Virus inoculum diluted in serum-free DMEM 
(Gibco; 100 μl per 12 mm well) was applied to the apical surface of HAE for 
2 hours at 37°C, then removed by aspiration. The apical surfaces were rinsed 
with PBS, and the cultures were incubated at 37°C. Viral growth kinetics 
were determined by performing apical surface washes with 300 μl of serum-
free DMEM, which were harvested after 30 minutes at 37°C and stored 
at –80°C until analysis. RSV viral titers in the apical washes were deter-
mined on HEp2 cells by titration and counting GFP-positive cells 24 hours 
pi. PIV3 viral titers were determined using a 50% tissue culture infectious 
dose (TCID50) assay on LLC-MK2 cell monolayers, with positive wells scored 
by GFP expression. En face fluorescent images of GFP-positive cells in 
HAE were captured using a Leica DMIRB Inverted Fluorescent Microscope 
equipped with a Retiga 1300 CCD camera (Q-Imaging). The proportion of 
the surface area of epithelium positive for GFP was determined by pixelating 
a black-and-white image, calculating the percentage of black pixels using 
ImageJ software (NIH) for 5 fields per culture, and averaging the results.
In vivo studies. Ten- to twelve-week-old female Golden Syrian hamsters 
(Harlan) were transiently anesthetized (methoxyflurane) and inoculated 
intranasally with 106 PFU of PIV3, PIV3-NS1, or PIV3-NS2 in 100 μl serum-
free L-15 Leibovitz medium (Gibco). Animals were euthanized and respira-
tory tissues harvested at the pi times indicated in the figures, for analysis 
of virus titers or histologic assessment. For virus titrations, whole lungs or 
nasal turbinates were weighed and homogenized in PBS. Viral titers were 
determined by standard plaque assay of the clarified supernatants, as pre-
viously described (67).
Histology and immunoprotocols
HAE cultures fixed in 4% paraformaldehyde in PBS were paraffin 
embedded, and 5-μm-thick histological sections were prepared. Sec-
tions were stained with H&E or Richardson’s stain. Immunodetection 
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of RSV antigen and β-tubulin IV was performed by blocking sections in 
3% BSA in PBS, followed by incubation with primary antibodies against 
GFP (rabbit polyclonal; Abcam) and β-tubulin IV (mouse monoclonal; 
Sigma-Aldrich). Immunoreactivity was detected using an anti-rabbit 
IgG conjugated to Alexa Fluor 488 and an anti-mouse IgG conjugated 
to Alexa Fluor 594 (Molecular Probes). To preserve and visualize api-
cal secretions of HAE, cultures were fixed in the alcohol-based fixative 
Omnifix (FR Chemical) as previously described (68) and stained with 
H&E. Immunohistochemistry for viral antigens were performed by 
blocking sections in 3% BSA and incubating with primary antibod-
ies against RSV (anti-RSV goat polyclonal; Meridian Life Sciences) or 
PIV3 (anti-PIV3 rabbit serum raised against sucrose-gradient-puri-
fied PIV3; ref. 69). Immunoreactivity was detected using anti-goat or 
anti-rabbit secondary antibodies conjugated to HRP, visualized using 
3,3′-diaminobenzidine (Sigma-Aldrich), and counterstained with hema-
toxylin. For TEM studies, HAE cultures were fixed in glutaraldehyde 
solution, then in an osmium tetroxide solution to preserve the hydrated 
external environment of the HAE, as previously described (68), and visu-
alized using standard TEM techniques.
For histologic examination of hamster tissues, excised nasal turbinates 
or whole lungs were immersion-fixed in 10% neutral-buffered formalin 
and embedded in paraffin, and histological sections were generated for 
examination and staining. Sections were stained with H&E. Immunode-
tection of viral antigen was performed using the anti-PIV3 rabbit serum 
mentioned above. To identify epithelial cells, a cytokeratin 18 antibody 
was used (mouse monoclonal; Abcam). Primary antibodies were detected 
using anti-mouse or anti-rabbit antibodies conjugated to HRP (Jackson 
ImmunoResearch Laboratories), visualized using 3,3′-diaminobenzidine 
(Sigma-Aldrich), and counterstained with hematoxylin.
RSV infection in human airways was determined in lung tissue obtained 
from infants with complete DiGeorge Syndrome naturally infected by 
RSV, and tissue was provided by the Duke University Pathology Speci-
men Repository in accordance with Duke University IRB protocols. RSV 
and cytokeratin 8/18 immunoreactivity was performed on histological 
sections using a Leica Bond-III automated stainers (Leica Microsystems 
Inc.). Following antigen retrieval with Novocastra Bond Epitope Retrieval 
1 solution (Leica Microsystems), sections were incubated with a primary 
antibody against RSV antigen (clones 5H5N, 2G12, 5A6, IC3; Vector Lab-
oratories) and detected with the Novocastra Bond Polymer Refine Detec-
tion system (Leica Microsystems). Immunostaining for cytokeratin 8/18 
used a proteinase K epitope retrieval solution (Dako North America Inc.), 
the primary antibody Novocastra cytokeratin 8/18 monoclonal antibody 
(clone 5D3; Leica Microsystems), and detection with the Novocastra Bond 
Polymer Refine Detection system.
Morphometric analysis of cell height and airway occlusion
XZ confocal images were acquired using a Leica SP5 confocal microscope. 
XZ images through the tallest region of a GFP-positive infected cell in fixed 
but unprocessed HAE cultures were imported into ImageJ software (NIH), 
where pixel height was measured and converted to microns using the elec-
tronic magnification measurement bar from the confocal image. A mini-
mum of 100 infected cells were measured from at least 3 individual donors.
The height of infected cells in the nasal respiratory tissue was determined 
by measuring pixel height of infected cells in images from fixed, viral anti-
gen–stained sections using ImageJ software (NIH) and converting to microns.
Occlusion of airways was determined by imaging infected airway regions 
from fixed, viral antigen–stained sections, converting to black-and-white 
images, pixelating, and calculating the percentage of black pixels within 
the airway lumen using ImageJ software. Airway occlusions were measured 
from 6 individual animals harvested on day 3 pi. All airways with antigen- 
positive cells (mean: ~30 airways per animal), except those larger than 
1 mm in diameter (~1 airway per animal), were measured, regardless of 
number of infected cells or extent of infection per airway.
Cell shedding
Cell shedding was quantified by determining the amount of dsDNA in api-
cal washes of HAE using the Quant-It PicoGreen dsDNA kit (Invitrogen). 
Apical washes were performed with 300 μl serum-free DMEM for 30 min-
utes at 37°C. Washes were harvested and stored at –80°C prior to anal-
ysis. Samples were diluted 5-fold in Tris-EDTA buffer, and dsDNA was 
measured in duplicate following the manufacturer’s instructions using 
a 96-well plate format. dsDNA concentration per sample was calculated 
based on fluorescence of a titrated dsDNA standard.
Percentage of area ciliated
Following removal of apical washes for titer and cell shedding assays, HAE 
cultures  were allowed to come to room temperature for 15 minutes to 
normalize cilia beat frequency, and 100 μl PBS was added apically. HAE 
cultures were placed on an inverted phase contrast microscope (TE2000; 
Nikon) using a ×20 objective, and high-speed (125-Hz) video images were 
captured with an 8-bit black-and-white camera (GS-310 Turbo; Megaplus). 
The analog signal was digitized via an analog-to-digital converter board 
(A/D; National Instruments). A digital computerized analysis system was 
used to analyze the acquired video images, using software based on Sisson- 
Ammons Video Analysis (70).
MCT rates
Following removal of apical washes for titer and shedding assays, green flu-
orescent microspheres (0.02% vol/vol, 1 μm; Invitrogen) were added to the 
apical surface and HAE cultures were incubated at 37°C. Time-lapse flu-
orescent images were obtained for 3 s using a Leica DMIRB Inverted Flu-
orescent Microscope equipped with a Retiga 1300 charge-coupled device 
camera (Q-Imaging). The rate of microsphere displacement was calculated 
as previously described (65).
Statistics
Statistical analysis of the data was performed using 2-tailed unpaired t 
test, ANOVA, or Mann-Whitney U test, as indicated in the figure legends. 
P < 0.05 was considered statistically significant unless otherwise noted.
Study approval
Protocols for the use of animals in these studies were reviewed and 
approved by the University of North Carolina at Chapel Hill IACUC 
(approval ID 11-118.0) and the Animal Care and Use Committee of the 
National Institute of Allergy and Infectious Diseases (NIAID ASP LID34E). 
Protocols for human cell culture were reviewed by the University of North 
Carolina at Chapel Hill Office of Human Research Ethics, which deter-
mined that the use of cells did not constitute human subject research as 
defined under federal regulations (45 CFR 46.102 [d or f] and 21 CFR 
56.102[c][e][l]) and did not require institutional review board approval. 
Protocols for using existing human autopsy specimens were reviewed by 
the Duke University Institutional Review Board, which determined that 
the protocols met the definition of research not involving human subjects 
as described in 45 CFR 46.102(f), 21 CFR 56.102(e), and 21 CFR 812.3(p) 
and satisfied the Privacy Rule as described in 45CFR164.514.
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